StockData
FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

FITLIFE BRANDS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.23−0.16 (-1.91%)

Close on Oct 19, 2026

Market cap
$81.53M
P/E (TTM)
43.3
Dividend yield
–

Earnings

Next report expected Nov 12, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 13, 2026Before market open$26.50M$0.20–
Q1 FY2026
Ended Mar 31, 2026
Apr 1, 2026Before market open$25.90M$0.16–
Q3 FY2025
Ended Sep 30, 2025
Nov 13, 2025Before market open$23.50M$0.09–
Q2 FY2025
Ended Jun 30, 2025
Aug 14, 2025Before market open$16.10M$0.18–
Q4 FY2024
Ended Dec 31, 2024
Mar 27, 2025During market hours$15.00M$0.21–
Q3 FY2024
Ended Sep 30, 2024
Nov 14, 2024Before market open$16.00M$0.43–
Q2 FY2024
Ended Jun 30, 2024
Aug 14, 2024During market hours$16.90M$0.53–
Q1 FY2024
Ended Mar 31, 2024
May 14, 2024Before market open$16.50M$0.43–
Q4 FY2023
Ended Dec 31, 2023
Mar 15, 2024Before market open–––
Q3 FY2023
Ended Sep 30, 2023
Nov 14, 2023Before market open–––
Q2 FY2023
Ended Jun 30, 2023
Aug 14, 2023During market hours–––

Company guidance

Outlook given with results on Mar 27, 2025, compared with the previous outlook

MeasurePeriodGuidancevs. prior
revenue declinefirst quarter of 2025-6% to -4% growthNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Fitlife Brands filed with the SEC